Discover how hot melt extrusion supports polypharmacy reduction and novel therapies for stroke and snakebite with expert insights.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

to use an existing COA or sponsors intending to qualify and use a new COA in the drug development process. Our findings show that, to date, the DDT Qualification Program has not significantly improved ...

Pharmaceutical Sciences−Engineering and Material Sciences, Vertex Pharmaceuticals, 50 Northern Avenue, Boston , Massachusetts 022102, United States ...

Specialty pharmaceuticals are now outpacing traditional drugs and currently account for 52% of the market. A particularly noteworthy development is the emergence of a private-label biosimilar to ...

We are looking to fill a PhD position (m/f/d) - Improving understanding of seasonal and interannual carbon and water fluxes using process-based modelling for 3 years, starting in September 2025 at the ...

The status is meant to provide financial incentives for drug development and FDA support in clinical trial design. It also allows seven years of market exclusivity should a therapy be approved. It is ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...